OUTLOOK THERAPEUTICS INC

Outlook Therapeutics Insider Buys 29,000 Shares as Company Prepares for Reverse Split and Private Placement

Insider buying at Outlook Therapeutics signals confidence amid a 200% share surge and a looming reverse split—what it means for investors and future valuation.

OUTLOOK THERAPEUTICS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

04/06/2026, 00:18

3 minutes to read

OUTLOOK THERAPEUTICS SEEKS A $5 M Boost As Director Ghiath M. Buys 8.5 M Shares at $0.59, Fueling Optimism for Near‑Term Growth and Strategic Moves.

Insider buy by Sukhtian Ghiath fuels Outlook Therapeutics optimism—22 m shares at $0.59, boosting liquidity, pipeline funding and potential upside.

OUTLOOK THERAPEUTICS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

02/06/2026, 03:45

3 minutes to read

Outlook Therapeutics Insider Faisal Ghiath Buys 122,174 Shares Amid FDA Win and Market Surge【News Flash】

Insider buying surges at Outlook Therapeutics as FDA win fuels investor confidence in the eye‑treatment pipeline, boosting stock momentum.

OUTLOOK THERAPEUTICS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

27/05/2026, 21:44

3 minutes to read